Why Isn't Tirzepatide Working for Me? (October 2026)

01 · The short answer

What to do first when tirzepatide doesn't seem to be working

Start by asking how long you have been on treatment and which dose you are on, because those two facts explain most disappointing results. Weight loss on Mounjaro is gradual by design. The first weeks on 2.5mg are an adjustment phase and losses are usually modest, while most measurable progress builds from 5mg onward.¹ If you are still in those early weeks, the honest answer is often that the medicine has not yet reached the dose where it does most of its work.

The second question is whether you are judging by the right measure. Early loss includes water weight, so the trend over weeks matters more than any single weigh-in.¹ A scale that jumps up after a salty meal, a hard workout or a hormonal shift tells you very little. Weigh at the same time of day, under the same conditions, and look at the direction over several weeks. Waist measurements, how your clothes fit and your appetite between meals are all useful extra signals.

Here is a quick triage to work through before you contact anyone.

For most people the right move is to stay the course while tightening the basics, then ask for a proper review. Your prescriber is the person who can decide whether a dose step-up is appropriate, and that decision should never be made alone. A plateau is not a reason to double doses or add unlicensed products.¹

If you take Mounjaro through us, your Mounjaro pen and consultation comes with ongoing monthly reviews, dose-titration support and follow-up assessments from the prescribing team, and all doses are currently in stock. You can read the wider picture on our weight loss clinic page.

If you would like a second set of eyes on the same worry, our companion guide to when Mounjaro isn't working covers the same ground from the dose-ladder angle.

Related guide: Glp 1 isn't working.

Related guide: Why isn't mounjaro working for me.

02 · Time and expectations

Have you given it enough time?

Often the answer is no, simply because expectations were set by headlines rather than by the trial timelines. Trials measured results at 72 weeks, so think in months, not days, and judge progress by trend, not individual weigh-ins.¹ A person who expects dramatic change in the first fortnight will nearly always feel let down, even when treatment is behaving exactly as designed.

The pace matters because the dose ladder is deliberately gradual. Every dose is held for at least 4 weeks, and then, if tolerated, a prescriber can consider the next strength. That slow climb protects you from the worst of the digestive side effects, but it also means the early pens are not where the largest effect lives. Three months in, most people are still on the lower rungs of the dose ladder, so trial-average losses at this stage are modest compared with the headline figures.²

It helps to be precise about what the trial actually showed. In SURMOUNT-1, average weight loss built month by month, with the full averages measured at 72 weeks, not at the early checkpoints.² So a sensible expectation for the early period on a standard titration is mid single digits as a percentage of body weight, with wide individual variation.² If you are sitting below even that, it does not automatically signal a problem. Slower early progress does not predict failure, and the dose you respond to may still be ahead of you.²

Another reason time feels slow is that early progress is noisy. Water weight shifts, bowel changes from the medicine, and normal daily fluctuation can hide a real downward trend for a few weeks. People who weigh daily and react to each number tend to feel as though nothing is happening, when a weekly average would show a clear slope. Try a simple routine: weigh once or twice a week at the same time, write it down, and compare four-week blocks rather than days.

There is also a formal checkpoint built into treatment. Treatment response is reviewed by your prescriber: if you have lost less than 5% of your starting weight after 6 months on the highest dose you can tolerate, your prescriber will discuss whether continuing or stopping is right for you.¹ Notice the wording: it refers to the highest tolerated dose, not to the starter pen. If you have only recently begun, you are very unlikely to have reached the point where that review applies.

Finally, remember what the medicine is for. It is used alongside a reduced-calorie diet and increased physical activity, and individual results vary.¹ Treat the first months as a period of learning how your own body responds, and use the monthly review to turn that learning into decisions. If you want a gentler introduction to realistic pacing, our guide on why Mounjaro can feel as if it is not working walks through the emotional side of slow early weeks.

03 · Dose still too low

Is your dose still too low?

It may well be, particularly if you are still on 2.5mg or 5mg. Mounjaro comes as a pre-filled multi-dose KwikPen in strengths of 2.5mg, 5mg, 7.5mg, 10mg, 12.5mg and 15mg.¹ The starter strength is there to let your body adjust, not to deliver the full effect. The first weeks on 2.5mg are an adjustment phase and losses are usually modest.¹

The trial figures show why dose matters. In SURMOUNT-1, people taking tirzepatide alongside diet and exercise lost on average 15% of their body weight on 5mg, 19.5% on 10mg and 20.9% on 15mg over 72 weeks, compared with 3.1% with lifestyle changes alone.² These are trial averages and individual results vary. They are not a promise, and they are not a target you have failed if you miss. But they do show that the averages rose with the dose, which is why a prescriber may discuss a step-up if you are not yet at your maximum.

Why not simply jump to a higher dose? Because tolerability comes first. Stepping up too fast tends to bring more nausea and other digestive effects, and the ladder exists to avoid that. The right pace is the one your prescriber sets after asking how you have been on your current strength. If side effects are heavy, the answer may be to stay put for longer; if they are mild and results are slow, a step-up may be reasonable.

There is a firm line here. Never increase the dose yourself and never use extra injections to compensate. A plateau is not a reason to double doses or add unlicensed products.¹ The licensed ladder is the safe route to a higher dose, and it works through a prescriber who knows your history.

If you are a customer of ours, the monthly review is the natural moment to raise this. Tell the prescribing team how long you have been on your current pen, how your appetite has changed, and what side effects you have noticed. Those three facts are the basis of a good step-up decision. If you are researching before you start, our page on why Mounjaro may not be working for you sets out the same dose logic in a shorter form.

One last point: a higher dose is not automatically a better dose for everyone. Some people reach a comfortable, effective level at a middle strength, and the aim of treatment is the dose that works for you while remaining tolerable, not the highest number on the ladder.

04 · Plateaus explained

Plateaus: why the scale stops moving

A plateau of a few weeks is normal and expected, and it is the single most common reason people say tirzepatide has stopped working. Weight loss on Mounjaro is not linear, and plateaus of a few weeks are normal and expected as the body adapts to a lower weight.¹

The pattern usually looks like this: a satisfying run of early loss, then a flat stretch that feels unfair because you are doing the same things. Nothing has necessarily gone wrong. Your habits may have drifted without you noticing.

Within the licence, the responses are practical and in a sensible order. First, review food intake honestly, because portions drift back up. Second, protect protein and activity. Third, check the basics, meaning sleep and alcohol. Fourth, discuss with your prescriber whether a dose step-up is appropriate if you are not yet at maximum.¹ That order matters, because the first three cost nothing and often resolve the stall.

What does an honest food review involve? Write down everything you eat and drink for a week, including the small things: milky coffees, a handful of nuts, sauces, snacks eaten while cooking, and drinks. Because the medicine makes you feel fuller sooner, many people find they graze on soft, calorie-dense foods that slip down easily. These go unnoticed because they do not trigger fullness the way a large meal would. Spotting them is usually more productive than cutting a main meal further.

Activity matters for a different reason. Protecting protein and movement helps you keep muscle while you lose, and that supports how you feel and function even when the scale pauses. You do not need an extreme programme; consistent walking and some resistance work are realistic starting points for most adults, though anyone with a health condition should check with their clinician first.

Sleep and alcohol are easy to dismiss and surprisingly influential. Poor sleep tends to raise hunger and cravings, and alcohol adds calories while lowering restraint around food. Neither is a moral failing; they are simply levers that can quietly tilt the balance.

Do not respond to a plateau by cutting food drastically, adding unlicensed products or skipping reviews. A stall that lasts a few weeks is part of the process. A stall that lasts many months, alongside the dose you are on being below maximum, is a different conversation to have with your prescriber.

05 · Food and basics

Food, protein, activity and daily habits

Tirzepatide supports a reduced-calorie diet; it does not replace one. It is used alongside a reduced-calorie diet and increased physical activity.¹ That framing explains why two people on the same dose can see very different results. The medicine changes how hungry you feel and how quickly your stomach empties, but what you do with that changed appetite is still yours.

Start with portions. In the early weeks on a medicine that makes you full sooner, it feels natural to eat small meals. Over time, appetite partly returns and portions drift upward. This is not failure; it is the most common reason a plateau lasts longer than it needs to. Use a smaller plate, serve once, and pause before seconds. Stop when you feel comfortably full, not when the plate is empty.

Next, look at what you drink. Sugary drinks, milky coffees, smoothies and alcohol deliver calories without much fullness, so they can undo a deficit without you realising. Water, tea and black coffee are straightforward swaps.

Protein deserves particular attention. When appetite is low, protein is often the first thing to shrink, and a diet that is light on protein makes it harder to feel satisfied and to preserve muscle. Build each meal around a protein source first, then add vegetables and wholegrains. If you struggle to eat enough, mention it to your prescriber rather than pushing through.

Activity does not need to be heroic. A daily walk, taking stairs and some strength work add up. Combined with consistent sleep, these habits help you feel better on treatment and make the medicine's effect more visible on the scales and tape measure.

Do not forget the practical side of the pen itself. Use the pen exactly as the patient information leaflet describes, rotate injection sites as instructed, and store pens as the leaflet directs. In-use pens can be kept out of the fridge at a temperature not above 30°C for up to 30 days after first use, and must then be thrown away; unopened pens belong in the fridge at 2–8°C until first use.¹³ If you ever doubt that a dose went in, or a pen has been stored badly, do not guess or inject extra; contact the pharmacy or your prescriber for advice. Needles, a sharps bin and injection guidance are included with every order from us.

Finally, be kind about the whole thing. Tracking helps most when it informs decisions rather than fuels guilt. Our free GLPTrackr app can help you log doses, weight and how you feel, so that your monthly review is based on real information rather than memory. If you want a checklist-style version of these habits, our page on troubleshooting when Mounjaro isn't working pulls them together.

06 · Feeling nothing

What if you feel nothing at all?

Feeling little or nothing on the starter dose is common, and it is not proof that the medicine is not working. The 2.5mg starting weeks are about adjustment, and experiences differ widely: some people notice appetite change and early loss in week one, others feel little until a higher dose, and both are normal.¹

It helps to understand what the medicine actually does. Tirzepatide activates two natural gut-hormone receptors at once, GIP and GLP-1. Together these help regulate appetite, slow how quickly the stomach empties, and improve the way the body responds to insulin.¹ In practice, most people feel fuller sooner and less hungry between meals, which supports a reduced-calorie diet. Notice the language: fuller sooner and less hungry between meals. It is not a switch that removes all interest in food, and it is not meant to feel like a stimulant or a sedative.

So what should you look for? Rather than waiting for a dramatic sensation, watch for subtle shifts. Do you finish smaller portions? Do you think about snacks less in the afternoon? Do you feel satisfied sooner at dinner? Those are the signals of the medicine working. If they are absent after a reasonable time on a given strength, that is useful information for your prescriber.

Side effects are another piece of the picture. Mild nausea, altered appetite and tiredness in the first days after each injection are the commonest early effects and usually settle.¹ Some people interpret the absence of these as a sign the medicine is not active, but absence of side effects is not a failure; it may simply mean you tolerate it well. Equally, strong side effects are not a sign of strong results.

On the other side of the coin, some people ask whether it is normal to have almost no appetite. Reduced appetite is expected, but if you are struggling to eat enough or feel unwell, get medical help straight away rather than pushing through; if you cannot keep fluids down, contact your clinical team — dehydration needs medical help straight away. Eating too little is not the goal, and your dose may need to stay where it is or be reviewed.

If after an honest period you still notice no change in hunger or fullness, it is reasonable to ask whether the dose could be increased within the licence. Your prescriber will weigh your response against tolerability. Do not switch to unlicensed products or inject more than prescribed in an attempt to feel something; that is not a safe way to chase an effect.

Finally, remember that perception is subjective. If you are measuring, tracking and seeing a gentle downward trend, the medicine may be working even if you do not feel it. For an empathetic take on this mismatch between feeling and results, see why it can feel like your Mounjaro is not working.

07 · Trial averages

What the trials show, and why averages can mislead

Trial averages describe groups, not individuals, so your own result may sit above or below them. In the SURMOUNT-1 trial of 2,539 adults, people taking tirzepatide alongside diet and exercise lost on average 15% of their body weight on 5mg, 19.5% on 10mg and 20.9% on 15mg over 72 weeks, compared with 3.1% with lifestyle changes alone.² These are trial averages, individual results vary, and treatment works alongside a reduced-calorie diet and increased physical activity, not instead of them.²

An average hides a spread. At 72 weeks, 85% of participants on 5mg, 89% on 10mg and 91% on 15mg had lost at least 5% of their body weight.² That tells us most people responded meaningfully, but also that a minority did not reach that level. The trial also reported that half of participants on 10mg and 57% on 15mg lost at least 20% of their body weight, which shows how wide the range was at the upper end as well.²

This is why the question "why do some people not respond?" has no single answer. People differ in biology, starting weight, medical conditions, other medicines, sleep, stress, food environment and how consistently they follow the plan. Some of these are changeable and some are not. A prescriber can help you work out which is which, which is more useful than comparing yourself to someone else's story online.

Beware of two traps. The first is comparing your month-three result with the 72-week averages. Those are different points on the curve, and the early period is expected to look modest. The second is treating a plateau as the end of progress. The trial averages came from people who also experienced stalls; they are the net result across the whole period.

It is also worth remembering that benefits go beyond the scales. In trials, weight loss on tirzepatide came with average improvements in waist size, blood pressure, cholesterol and blood-sugar measures, and most participants with prediabetes returned to normal blood-sugar levels.² These are trial-average secondary outcomes, not promises. But they mean that if your weight is moving slowly, your health markers may still be improving, which is something worth asking your clinician to check.

When you discuss results with your prescriber, bring a record: starting weight, current weight, waist measurement, dose history, side effects and honest notes on eating and activity. A complete picture lets the review be specific rather than general. If your response is below what you hoped, the review is the place to decide on continuing, adjusting or stopping, not a reason to quit privately or change the plan alone.

For a view on how this compares with other options, our weight loss clinic page explains what is available through a regulated pharmacy, and why treatment is always reviewed rather than set and forgotten.

08 · Review and next steps

When to ask for a review, and what happens next

Ask for a review when you have been on a stable, tolerated dose for a sensible period and your trend is flat, or earlier if you feel unwell. Treatment response is reviewed by your prescriber: if you have lost less than 5% of your starting weight after 6 months on the highest dose you can tolerate, your prescriber will discuss whether continuing or stopping is right for you.¹ That sentence describes a conversation, not an automatic cut-off, and it exists to protect you from staying on a treatment that is not helping.

What might a review change? Possible outcomes include staying on the current dose for longer, stepping up within the licence if you are not yet at maximum, adjusting the pace if side effects are limiting you, or discussing alternatives if the medicine is not suiting you. Your prescriber will also consider whether anything else in your health or medicines could be affecting results.

If you stop, plan for it. Tirzepatide has a half-life of about five days, so after a final dose it takes roughly four to five weeks to clear the system. There is no way to speed this up, and nothing needs doing while it clears.¹ Stopping should always be planned with your prescriber. In SURMOUNT-4, people who stopped tirzepatide after 36 weeks regained on average 14% of body weight over the following year, while those who continued treatment lost a further 5.5% on average.¹⁴ That is a reason to talk through stopping with your prescriber rather than drifting off treatment.

Be cautious about shortcuts. A plateau is not a reason to double doses or add unlicensed products.¹ Be wary of anyone offering to supply without a consultation or prescription, or promising specific results; those are warning signs of counterfeit or unsafe products. Genuine Mounjaro is a prescription-only medicine, supplied only after an online consultation reviewed by a GPhC-registered prescriber. You can check any pharmacy on the GPhC register; ours is GPhC 9012878.⁷

If you notice a new or worrying symptom, tell your prescriber and consider reporting it through the Yellow Card scheme.¹⁹ That applies whether or not you think the symptom is related to the medicine.

On the practical side of ordering, the process is straightforward: a free online consultation, a review by a GPhC-registered prescriber, dispensing and dispatch by our registered pharmacy, and free next-day tracked delivery. Repeat orders re-check suitability, and there is no auto-shipping, so you stay in control. Support is available Monday to Friday, 9am to 5pm, by email at support@everydaymeds.co.uk or phone on 0333 207 0413.

Mounjaro is available on the NHS, but access is being phased in over several years, with NICE recommending it for adults with a BMI of at least 35 plus at least one weight-related condition.⁴ Whichever route you use, the review is where a flat result turns into a plan.

09 · Serious side effects

Serious side effects: when to get help straight away

Serious side effects are uncommon but need urgent attention. Seek immediate medical help for: severe, persistent stomach pain that may spread to your back, with or without vomiting (possible pancreatitis); pain in the upper right abdomen, fever or yellowing of skin/eyes (possible gallbladder problems); or signs of a severe allergic reaction such as swelling of the face or throat and difficulty breathing. If you take insulin or a sulfonylurea alongside Mounjaro, watch for low blood sugar (shakiness, sweating, confusion) — your prescriber may need to adjust those medicines.¹